Liposarcoma medical therapy

Jump to navigation Jump to search

Liposarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Liposarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Liposarcoma medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Liposarcoma medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Liposarcoma medical therapy

CDC on Liposarcoma medical therapy

Liposarcoma medical therapy in the news

Blogs on Liposarcoma medical therapy

Directions to Hospitals Treating Liposarcoma

Risk calculators and risk factors for Liposarcoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Treatment of liposarcoma is based on an integrated approach by a multidisciplinary team based on the medical history and physical examination, imaging and biopsy studies of the tumor. Chemotherapy, chemoradiation, immunotherapy and targeted therapy are the different types of medical therapy for liposarcoma.

Medical Therapy

Chemotherapy may be used with radiation therapy either before or after surgery to try to shrink the tumor or kill any remaining cancer cells. In general, chemotherapy effects for soft tissue sarcoma have had little impact as opposed to other cancers. If the cancer has spread to other areas of the body, chemotherapy may be used to shrink tumors and reduce the pain and discomfort they cause, but is unlikely to eradicate the disease. The use of chemotherapy to prevent the spread of soft tissue sarcomas has not been proven to be effective. Patients with soft tissue sarcomas usually receive chemotherapy intravenously (injected into a blood vessel).

  • Chemotherapy

It is used to kill cancer cells by various mechanisms like damaging DNA or damaging the making of DNA. It can be used as primary, adjuant or neoadjuant therapy. It is also used to treat metastasis also. Usually 2 or more chemotherapy drugs are given in combination to treat the disease. They are given in cycles of treatment days followed by days of rest. The length of the cycles varies depending on the drug used. The cycles of chemotherapy helps the body to recover faster.

  • Chemoradiation

Sometimes the targeted therapy is given along with radiation . They may be given together or at different intervals.

  • Targeted therapy

It stops the growth of the molecules involved in growth of cancer cells. It blocks the growth signals. Most targettd therapy comes in pill form and some needs to be injected.

  • Immunotherapy

Immune system is the body's natural defense against infection and disease. Immunotherapy increases your activity of the immune system and improves body's ability to find and destroy cancer cells. Few of the drugs used for immune therapy are listed below.[1]

Drug Type of drug
Bevacizumab Targeted therapy
Celecoxib Targeted therapy
Crizotinib Targeted therapy
Dacarbazine Chemotherapy
Dasatinib Targeted therapy
Docetaxel Chemotherapy
Doxorubicin Chemotherapy
Epirubicin hydrochloride Chemotherapy
Everolimus Chemotherapy
Gemcitabine hydrochloride Chemotherapy
Ifosfamide Chemotherapy
Imatinib mesylate Targeted therapy
Interferon alpha 2B Immunotherapy
Mesna Chemotherapy
Methotrexate Chemotherapy
Nilotnib Chemotherapy
Paclitaxel Chemotherapy
Pazopanib Targeted therapy
Regorafenib Targeted therapy
Sorafenib tosylate Targeted therapy
Sirolimus Chemotherapy
Sulindac Chemotherapy
Sunitinib malate Targeted therapy
Tamoxifen citrate Targeted therapy
Temozolamide Chemotherapy
Toremifene citrate Targeted therapy
Vinblastine citrate Chemotherapy
Vinblastine tartarate Chemotherapy

Regimen

Drugs Dose
Doxurubicin Doxurubicin 75 mg/m2; 28 day cycle
Pegylated liposomal doxurubicin 40-50 mg/m2 ; 28 day cycle
AI regimen Doxurubicin 25 mg/m2, Ifosfamide 3g/m2 21 day cycle
MAID regimen Doxurubicin 20 mg/m2, ifosfamide 2.5g/m2, Dacarbazine 300mg/m2 21 day cycle
AD regimen Doxurubicin 20 mg/m2, Dacarbazine 300mg/m2; 21 day cycle
Metronomic cyclophosphamide Oral daily cyclophosphamide 50mg/day for 21 dyas on 28 day cycle
Docetaxel-Gemcitabine Gemcitabine 900 mg/m2 , Docetaxel 100 mg/m2 for 21 day cycle
Trabectidin Trabectidin 1.5mg/m2 21 day cycle[2]

References

  1. "NCCN".
  2. "Liposarcoma".

Template:WikiDoc Sources